NEW YORK, Dec. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. ("Skye Bioscience, Inc." or the "Company") (NASDAQ: SKYE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Skye Bioscience, Inc. investors who were adversely affected by alleged securities fraud between November 4, 2024 and October 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslr ...

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. ("Skye Bioscience, Inc." or the "Company") (NASDAQ: SKYE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Skye Bioscience, Inc. investors who were adversely affected by alleged securities fraud between November 4, 2024 and October 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/p ...

New York, New York--(Newsfile Corp. - December 15, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Skye Bioscience, Inc. (NASDAQ: SKYE) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Skye Bioscience caused the company to misrepresent or fail to disclose that: (i) nimacimab was less effective than represented; (ii) accordingly, nimacimab's clinical, regulatory, and commercial prosp ...

NEW YORK, Dec. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Skye Bioscience, Inc. (NASDAQ: SKYE). Shareholders who purchased shares of SKYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/skye-bioscience-inc-loss-submission-form/?id=180162&from=4  CLASS PERIOD: Novem ...

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Skye securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

核心诉讼事件 - 格罗斯律师事务所向Skye Bioscience公司股东发布集体诉讼通知 诉讼涉及公司在2024年11月4日至2025年10月3日期间可能存在的虚假或误导性陈述 [1] - 诉讼指控核心内容包括 公司主要候选产品nimacimab的实际效果低于公司向投资者传达的水平 其临床、监管和商业前景被夸大 导致公司公开陈述在相关时间内存在重大虚假和误导性 [1] 诉讼程序细节 - 集体诉讼周期为2024年11月4日至2025年10月3日 股东参与诉讼或申请首席原告的截止日期为2026年1月16日 [1][2] - 鼓励在上述期间购买Skye Bioscience股票的股东联系律师事务所 参与诉讼无需担任首席原告 且股东参与本案无需任何费用或义务 [1][2] 律师事务所信息 - 格罗斯律师事务所是一家全国知名的集体诉讼律师事务所 其使命是保护因欺骗、欺诈和非法商业行为而遭受损失的投资者权利 [3] - 该律所致力于确保公司遵守负责任的商业行为并践行良好的企业公民义务 旨在为因公司虚假陈述或重大信息遗漏导致股价被人为抬高而遭受损失的投资者追偿 [3]

U.S. after-hours trading on Wednesday saw a wave of gains across several small-cap and micro-cap biotech names, with a mix of catalyst-driven moves and sentiment-based rebounds. While a few companies advanced on upcoming clinical milestones or recent data presentations, others climbed despite having no new corporate developments, reflecting renewed interest in high-volatility biotech names during extended trading.Below are the notable after-hours gainers:Agape ATP Corp. (ATPC) — Up 29.41% After HoursAfter ...

诉讼概述 - 律师事务所Levi & Korsinsky, LLP通知Skye Bioscience, Inc投资者有关一项集体诉讼证券诉讼 [1] - 诉讼旨在为在2024年11月4日至2025年10月3日期间因涉嫌证券欺诈而遭受不利影响的投资者挽回损失 [1] - 潜在集体成员需在2026年1月16日前请求法院指定其为首席原告 [3] 指控内容 - 指控称被告做出了虚假陈述和/或隐瞒了事实 [2] - 具体指控包括公司的主要候选产品nimacimab的效果不如被告向投资者引导的那样有效 [2] - 指控认为因此nimacimab的临床、监管和商业前景被夸大 [2] - 指控结果是被告在相关时间的所有公开陈述都存在重大虚假和误导性 [2] 投资者参与信息 - 在相关时间段内遭受损失的投资者有资格参与 [3] - 参与集体诉讼无需支付任何自付费用或成本 [3] - 投资者可通过提供的链接、电子邮件或电话联系律师事务所获取更多信息或提交申请 [1][3] 律师事务所背景 - Levi & Korsinsky律师事务所在过去20年里为受损股东追回了数亿美元 [4] - 该事务所在处理高风险的复杂证券诉讼方面拥有丰富专业知识 [4] - 该事务所拥有超过70名员工的团队为客户服务 [4] - 该事务所已连续七年被ISS证券集体诉讼服务评为美国顶级证券诉讼公司之一 [4]

NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Skye Bioscience, Inc. (NASDAQ: SKYE). Shareholders who purchased shares of SKYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/skye-bioscience-inc-loss-submission-form/?id=179741&from=3 CLASS PERIOD: Nov ...

NEW YORK, Dec. 8, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Skye Bioscience, Inc. (NASDAQ: SKYE). Shareholders who purchased shares of SKYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/skye-bioscience-inc-loss-submission-form/?id=179728&from=4 CLASS PERIOD: Novembe ...